Drug · DIN 02463504
OZANEX
Authorized, but not sold for a year or more
Authorized, but the company reports it has not been sold in Canada for at least 12 months.
Status Dormant since July 11, 2024; first marketed January 4, 2018.
- Drug Identification Number (DIN)
- 02463504
- Company (DIN owner)
- Ferrer Internacional SaBarcelona, Catalonia, Spain
- Schedule
- Prescription
- Dosage form
- Cream
- Route
- Topical
- Therapeutic class (ATC)
- Ozenoxacin D06AX14
- Class
- Human
- Record last updated
- July 29, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| OZENOXACIN | 1 % | W/W |
Notices of Compliance
Health Canada approvals that name this DIN.
- May 1, 2017: NOC 19219New Drug Submission (NDS)